(Becker News) President Joe Biden spoke to reporters about the rise of a mild but contagious strain of Covid-19. The president told them about a request for new additional funding for a vaccine “that works” that will be recommended for all Americans regardless of prior immunity or previous Covid shots.
“I signed off this morning on a proposal we have to present to the Congress – a request for additional funding for new vaccine that is necessary, that works… Tentatively it is recommended, it would likely be recommended, everybody get it. No matter whether they got it before or not.”
At the same time, Pfizer is actively marketing its revised Covid-19 vaccine, with news articles suggesting that the updated shots generate neutralizing antibodies against the ‘Eris’ subvariant in mice. Eris and Pirola are the most recent Covid-19 subvariants.
“Whether or not this is going to be more transmissible than what we’ve seen before, that’s the key question,” he continued. “Certainly at this point, it doesn’t appear more pathogenic, so it doesn’t appear to be more dangerous, but it may be more transmissible than the strains that are circulating now. And in that case, it could overtake them. It’s too early to know. The testing’s underway.
“So the data looks like the new booster, which is based on BA 1.15, which was the strain that emerged last spring, looks like it will protect against these new variants,” he claimed.
Dr. Robert Malone broke down Gottlieb’s claims and his conflicts of interest alarming the public about the new Covid variants.
“So, who is Dr. Scott Gottlieb, and why should we care about whether or not he is ‘concerned’?” Dr. Malone asked. “Dr. Gottlieb was the commissioner of the FDA during the height of COVID, he is now is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion and biotech company Illumina. He also sits on the board for NEA, a global venture capital firm. My insider friends also say that Dr. Gottlieb is/was on advisory boards to the CIA. You know, that CIA – that founded Moderna as a start-up and continues to capitalize it via the CIA venture capital firm InQTel.”
“Yeh- no ‘conflict of interest‘ in his statement above, as Moderna, Pfizer stocks are rising amid ‘new Covid variants’,” he sarcastically added.
Dr. Malone then points out those who are at risk from the new Covid variants, which should look familiar to anyone who has been following the pandemic since early 2020.
“As usual, there is only one group who is at any risk attributable to COVID at this point, and even that is a very low risk,” he said. “That risk group being the age cohort 70+ years old. In the 70+ age group, about 3 people are being admitted to the hospital WITH COVID-19 per 100,000 per week. For all other age cohorts, the risk of hospital admission is near next to nothing.”
“Although I have not seen the primary data, some reports state that Eris may be more transmissible than other variants, but all indications are that it does not appear to be more severe than Omicron,” he continued. “There is also a new variant called BA.2.86 and nicknamed Pirola. But so far, symptoms associated with that virus also appear to be mild.”
Pfizer’s profits are down 25% on the year, but the company is looking to rebound based on booster shots for these new subvariants.